Absence of the human CYP2C8*3 allele in Ugandan children exposed to Plasmodium falciparum malaria

被引:3
作者
Paganotti, Giacomo Maria [1 ,2 ]
Cosentino, Valentina [2 ]
Russo, Gianluca [2 ]
Tabacchi, Francesca [2 ]
Gramolelli, Silvia [3 ]
Coluzzi, Mario [2 ]
Romano, Rita [2 ]
机构
[1] Univ Botswana, Univ Penn, Gaborone, Botswana
[2] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy
[3] Hannover Med Sch, Inst Virol, Hannover, Germany
关键词
Plasmodium falciparum malaria; CYP2C8; Pharmacogenetics; Uganda; pfmdr1; Malaria drug resistance; GENETIC POLYMORPHISMS; CYP2C8; POLYMORPHISMS; PREVALENCE; METABOLISM; PFMDR1; PACLITAXEL;
D O I
10.1016/j.meegid.2014.08.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Study of host pharmacogenetics can improve our knowledge of mechanisms of drug resistance selection and spread. This issue has recently been addressed with respect to chloroquine and amodiaquine in malaria endemic areas of West and East Africa. Here we report, from surveys performed in two different areas of Uganda, that the human CYP2C8*3 allele, which had been reported to be strongly associated with parasite drug resistance in Zanzibar, is absent, being a marker of genetic admixture of the Zanzibari population with a Caucasoid component. Moreover, a retrospective analysis of CYP2C8*2 and the Plasmodium falciparum drug resistant pfmdr1 86Y allele does not show any association, which may be related to the high level of drug resistance. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:432 / 435
页数:4
相关论文
共 33 条
[1]   Cytochrome P450 pharmacogenetics in African populations [J].
Alessandrini, Marco ;
Asfaha, Sahle ;
Dodgen, Tyren Mark ;
Warnich, Louise ;
Pepper, Michael Sean .
DRUG METABOLISM REVIEWS, 2013, 45 (02) :253-275
[2]  
[Anonymous], 2013, WORLD MALARIA REPORT
[3]   CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes [J].
Bahadur, N ;
Leathart, JBS ;
Mutch, E ;
Steimel-Crespi, D ;
Dunn, SA ;
Gilissen, R ;
Van Houdt, J ;
Hendrickx, J ;
Mannens, G ;
Bohets, H ;
Williams, FM ;
Armstrong, M ;
Crespi, CL ;
Daly, AK .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (11) :1579-1589
[4]   CYP2C8 polymorphism among the Portuguese [J].
Cavaco, I ;
Piedade, R ;
Gil, JP ;
Ribeiro, V .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) :168-170
[5]   CYP2C8 polymorphism frequencies among malaria patients in Zanzibar [J].
Cavaco, I ;
Strömberg-Nörklit, J ;
Kaneko, A ;
Msellem, MI ;
Dahoma, M ;
Ribeiro, VL ;
Bjorkman, A ;
Gil, JP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (01) :15-18
[6]   CYP2C8 Status of Patients With Malaria Influences Selection of Plasmodium falciparum pfmdr1 Alleles After Amodiaquine-Artesunate Treatment [J].
Cavaco, Isa ;
Martensson, Andreas ;
Froberg, Gabrielle ;
Msellem, Mwinyi ;
Bjorkman, Anders ;
Gil, Jose P. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (04) :687-688
[7]   THE SHIRAZI COLONIZATION OF EAST-AFRICA [J].
CHITTICK, N .
JOURNAL OF AFRICAN HISTORY, 1965, 6 (03) :275-294
[8]   Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid [J].
Dai, D ;
Zeldin, DC ;
Blaisdell, JA ;
Chanas, B ;
Coulter, SJ ;
Ghanayem, BI ;
Goldstein, JA .
PHARMACOGENETICS, 2001, 11 (07) :597-607
[9]   Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria [J].
Djimdé, AA ;
Doumbo, OK ;
Traore, O ;
Guindo, AB ;
Kayentao, K ;
Diourte, Y ;
Niare-Doumbo, S ;
Coulibaly, D ;
Kone, AK ;
Cissoko, Y ;
Tekete, M ;
Fofana, B ;
Dicko, A ;
Diallo, DA ;
Wellems, TE ;
Kwiatkowski, D ;
Plowe, CV .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (05) :558-563
[10]   The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin [J].
Duraisingh, MT ;
Jones, P ;
Sambou, I ;
von Seidlein, L ;
Pinder, M ;
Warhurst, DC .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 108 (01) :13-23